Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.30 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24115347 | 0.75 | ALDH1A1 (0.32) | ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL24115393 | 0.68 | — | — | |
| SCHEMBL20652729 | 0.66 | ALOX15 (0.30) | ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL5285479 | 0.65 | SMN1; SMN2 (0.37) | ALDH1A1SMN1; SMN2KDM4EMAPTHSD17B10 | |
| SCHEMBL2402704 | 0.65 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL24115263 | 0.63 | ALDH1A1 (0.57) | ALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL2402694 | 0.63 | EPHX1 (0.33) | ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL11363709 | 0.63 | SMN1; SMN2 (0.33) | ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL13593226 | 0.63 | ALDH1A1 (0.57) | ALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL20652618 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021254919-A1 | SELECTIVE TMPRSS2 INHIBITORS AND MEDICAL USE THEREOF | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-12-23 | — | — | WO | disclosed |
| EP-3925667-A1 | SELECTIVE TMPRSS2 INHIBITORS AND MEDICAL USE THEREOF | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-12-22 | — | — | EP | disclosed |